# Nina Bhardwaj

Source: https://onco.cc/people/nina-bhardwaj/  
OnCo record `nina-bhardwaj` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Nina Bhardwaj is a dendritic-cell immunologist running personalised neoantigen vaccine trials.

## Summary

Nina Bhardwaj is Director of Immunotherapy and holds the Ward-Coleman Chair in Cancer Research at The Mount Sinai Hospital and Tisch Cancer Institute. She is a dendritic cell immunologist and a pioneer of dendritic cell biology in human immunity. She leads the PGV001 personalised neoantigen peptide vaccine programme, and her selected paper reports a phase 1 trial of the safety and immunogenicity of a multi-peptide personalised genomic vaccine as adjuvant treatment of solid cancers. Her current work spans personalised neoantigen vaccines and off-the-shelf cancer vaccines.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Director of Immunotherapy; Ward-Coleman Chair in Cancer Research
- Specialisms: Dendritic cells; Cancer vaccines; Personalised neoantigen vaccines

## Sources

- Mount Sinai profile: https://profiles.mountsinai.org/nina-bhardwaj
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Bhardwaj%20N%5BAuthor%5D

## Connected records

- technologies: [Off-the-shelf cancer vaccines](https://onco.cc/technologies/shared-antigen-vaccine/), [Personalised neoantigen (mRNA) vaccines](https://onco.cc/technologies/neoantigen-mrna-vaccine/)
- institutions: [The Mount Sinai Hospital / Tisch Cancer Institute](https://onco.cc/institutions/mount-sinai/)
- terms: [Neoantigen](https://onco.cc/terms/neoantigen/)

---
JSON: https://onco.cc/api/v1/entities/nina-bhardwaj.json